AstraZeneca PLC (AZN) Sentiment
30-day SentiSense Score 17.84 · Bullish · ▼ cooling · as of 2026-09-23
AZN sentiment is bullish (30-day SentiSense Score 18) and cooling from a month ago; today's read is hotter at 26, above its 30-day average. Attention averages ~26 mentions/day (20 today).
- Sentiment (30-day)
- Bullish
- SentiSense Score (30-day avg)
- 17.84
- Today's read
- 25.58 (Bullish)
- Mentions / day (30-day avg)
- 26 (20 today)
Where the conversation is happening
- News
- Bullish · 83% of mentions
- X
- Bullish · 7% of mentions
- Neutral · 4% of mentions
- Substack
- Bullish · 3% of mentions
- YouTube
- Bullish · 3% of mentions
Related tickers
What's driving it
- Amgen's Imdelltra with AstraZeneca's Imfinzi improves survival in late-stage small-cell lung cancer trial (+1)
- AstraZeneca's COPD drug tozorakimab cuts exacerbations by roughly 30% in Phase III trials (+0.81)
- AstraZeneca's Etcamah Gains FDA Accelerated Approval for ESR1‑Mutated Breast Cancer, Paired with Guardant's Liquid Biopsy Clearance (+0.87)
Live SentiSense Score, sentiment history, and per-source breakdown for AstraZeneca PLC on SentiSense.
See how AZN's sector compares in the market sentiment heatmap